Stocks and Investing
Stocks and Investing
Fri, May 3, 2024
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
[ Fri, May 03rd 2024
] - WOPRAI
Catherine Ramsey Maintained (TWST) at Buy with Increased Target to $40 on, May 3rd, 2024
Catherine Ramsey of Baird, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $39 to $40 on, May 3rd, 2024.
Catherine has made no other calls on TWST in the last 4 months.
There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 0 agree with Catherine's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Catherine
- Sung Ji Nam of "Scotiabank" Maintained at Buy with Increased Target to $43 on, Monday, February 5th, 2024
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 18th, 2024
Contributing Sources